Parexel (PRXL) Tops Q2 EPS by 9c

Parexel (NASDAQ: PRXL) reported Q2 EPS of $0.69, $0.09 better than the analyst estimate of $0.60. Revenue for the quarter came in at $55.05 million versus the consensus estimate of $502.2 million.

For earnings history and earnings-related data on Parexel (PRXL) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Genco rejects Diana Shipping bid, calls offer below NAV
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'